Chronic Obstructive Pulmonary Disease

DefinitionNLM MeSH D029424

A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.

Source: U.S. National Library of Medicine — MeSH (Pulmonary Disease, Chronic Obstructive)

Drugs reporting Chronic Obstructive Pulmonary Disease (26)

Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.

1. 1Helicobacter Pylori2743%
2. 2Ammonium Chloride8235%
3. 3Racepinephrine1434%
4. 4Acetylcholine3329%
5. 5Bismuth Subgallate613%
6. 6Aclidinium77912%
7. 7Roflumilast6439.7%
8. 8Tipranavir1047.5%
9. 9Arformoterol146.8%
10. 10Manganese Sulfate56.3%
11. 11Ensifentrine716.3%
12. 12Rna15.9%
13. 13Revefenacin415.5%
14. 14Theophylline6495.3%
15. 15Ipratropium1,9725.1%
16. 16Tiotropium6,9364.6%
17. 17Olodaterol2104.0%
18. 18Formoterol5,0324.0%
19. 19Pralidoxime13.8%
20. 20Umeclidinium2,4013.8%
21. 21Eflapegrastim13.6%
22. 22Oxygen1,5923.4%
23. 23Acetylcysteine3073.4%
24. 24Vilanterol2,9593.3%
25. 25Salmeterol3,4893.2%
26. 26Fluticasone6,2912.4%

Related reactions

Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.

• Productive Cough10 shared · 0.24
• Wheezing13 shared · 0.21
• Asthma15 shared · 0.17
• Chest Discomfort12 shared · 0.12
• Therapeutic Product Effect Incomplete9 shared · 0.11
• Dysphonia4 shared · 0.10
• Sleep Disorder4 shared · 0.09
• Product Complaint3 shared · 0.09
• Wrong Technique In Device Usage Process3 shared · 0.08
• Loss Of Personal Independence In Daily Activities3 shared · 0.08

Literature

Recent PubMed references pinned to Pulmonary Disease, Chronic Obstructive as a MeSH major topic. About the reaction term itself — not about any specific drug.

• [The research progress of neutrophil-to-lymphocyte ratio level in chronic obstructive pulmonary disease with lung cancer].
  Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology · 2026 · Wei L, Liang Y, Sun X, et al.
  PMID 42206711
• EPAS1 and VEGFA Polymorphisms Modulate COPD Susceptibility in a High-Altitude Population: A Case-Control Study.
  International journal of chronic obstructive pulmonary disease · 2026 · Lin L, Zhang Y, Fu X, et al.
  PMID 42206079DOI 10.2147/COPD.S585856
• Smoking-Attributable Burden of Chronic Obstructive Pulmonary Disease from 1990 to 2021: Temporal Trends and Evidence from the Global Burden of Disease Study.
  International journal of chronic obstructive pulmonary disease · 2026 · Ma T, Yue X, Rong S, et al.
  PMID 42206078DOI 10.2147/COPD.S599370
• Self-management experiences and needs in patients with chronic obstructive pulmonary disease: a meta-synthesis of qualitative studies.
  BMJ open · 2026 · Chen Y, Zeng H, Hongmin R, et al.
  PMID 42203282DOI 10.1136/bmjopen-2025-105800
• Implementation of long-term noninvasive positive airway pressure therapy in patients with COPD: a systematic review and meta-analysis of acceptance and adherence.
  European respiratory review : an official journal of the European Respiratory Society · 2026 · Laratta CR, Moore L, Kirkland SW, et al.
  PMID 42203234DOI 10.1183/16000617.0231-2025
• Muscle sympathetic nerve activity in COPD: a systematic review and meta-analysis.
  European respiratory review : an official journal of the European Respiratory Society · 2026 · Duiker B, Shirazi S, Sivak A, et al.
  PMID 42203232DOI 10.1183/16000617.0267-2025